CRIS Current Research Information System

PALMERINI, TULLIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.429
AS - Asia 4.031
EU - Europa 3.675
AF - Africa 368
SA - Sud America 278
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 13.791
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.374
SG - Singapore 1.172
CN - Cina 1.055
VN - Vietnam 986
GB - Regno Unito 847
DE - Germania 551
IT - Italia 526
SE - Svezia 488
HK - Hong Kong 317
IN - India 232
UA - Ucraina 223
BR - Brasile 199
RU - Federazione Russa 190
IE - Irlanda 165
FR - Francia 163
NL - Olanda 153
CI - Costa d'Avorio 103
CH - Svizzera 74
KR - Corea 71
SC - Seychelles 70
ZA - Sudafrica 69
BG - Bulgaria 67
FI - Finlandia 61
JP - Giappone 61
TG - Togo 61
EE - Estonia 60
NG - Nigeria 54
JO - Giordania 52
AR - Argentina 37
CA - Canada 31
BE - Belgio 27
IR - Iran 22
MX - Messico 19
AT - Austria 16
PL - Polonia 15
EC - Ecuador 14
ID - Indonesia 10
CL - Cile 9
TR - Turchia 9
LT - Lituania 8
RO - Romania 8
CO - Colombia 7
UZ - Uzbekistan 7
BD - Bangladesh 6
ES - Italia 6
AU - Australia 5
EG - Egitto 5
GR - Grecia 5
PK - Pakistan 5
PY - Paraguay 5
DK - Danimarca 4
HR - Croazia 4
PE - Perù 4
PT - Portogallo 4
A2 - ???statistics.table.value.countryCode.A2??? 3
IQ - Iraq 3
LB - Libano 3
TW - Taiwan 3
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
LA - Repubblica Popolare Democratica del Laos 2
MN - Mongolia 2
MY - Malesia 2
OM - Oman 2
SA - Arabia Saudita 2
SI - Slovenia 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
AQ - Antartide 1
BO - Bolivia 1
BW - Botswana 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
FK - Isole Falkland (Malvinas) 1
GI - Gibilterra 1
GT - Guatemala 1
HT - Haiti 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
ML - Mali 1
NZ - Nuova Zelanda 1
PH - Filippine 1
TH - Thailandia 1
VE - Venezuela 1
Totale 13.791
Salva come PNG Salva come JPEG
Città #
Singapore 836
Southend 719
Ashburn 626
Fairfield 543
Chandler 436
Hong Kong 316
Santa Clara 295
Wilmington 249
Woodbridge 249
Seattle 241
Houston 229
Ho Chi Minh City 210
Princeton 203
Cambridge 183
Dong Ket 182
Ann Arbor 176
Beijing 176
Dublin 165
Hefei 165
Jacksonville 148
Hanoi 146
Boardman 136
Abidjan 102
New York 98
Westminster 80
Bologna 79
Padova 71
Berlin 68
Bern 68
Turin 66
Sofia 64
Lomé 61
Nanjing 61
Los Angeles 60
Seoul 60
Tokyo 57
Bremen 54
Abeokuta 53
Amman 52
Buffalo 50
Munich 50
Milan 46
Saint Petersburg 38
Dallas 36
Helsinki 36
Jinan 36
San Diego 35
Frankfurt am Main 34
Redondo Beach 32
Nanchang 30
Mülheim 29
Brussels 26
Chicago 26
Changsha 24
London 24
Dearborn 22
Medford 22
Rome 22
Pune 21
Biên Hòa 20
Da Nang 20
Falkenstein 20
Guangzhou 20
Shenyang 20
Tianjin 20
Turku 20
Yubileyny 20
Shanghai 19
São Paulo 19
The Dalles 19
Haiphong 18
Jiaxing 18
Hebei 17
Mahé 17
Quận Bình Thạnh 17
Falls Church 16
Florence 16
Lanzhou 16
Zhengzhou 16
Des Moines 15
Verona 15
Mountain View 14
Toronto 14
Washington 14
Bengaluru 13
Olalla 13
Phoenix 13
Ha Long 12
Ningbo 11
Norwalk 11
Taiyuan 11
Taizhou 11
Düsseldorf 10
Haikou 10
Leawood 10
Brooklyn 9
Bühl 9
Can Tho 9
Hangzhou 9
Redwood City 9
Totale 9.032
Salva come PNG Salva come JPEG
Nome #
A randomised study comparing the antiplatelet and antinflammatory effect of clopidogrel 150mg/day versus 75mg/day in patients with ST-segment elevation acute myocardial infarction and poor responsiveness to clopidogrel: Results from the DOUBLE study. 240
A Comparison Between Coronary Angioplasty and Coronary Artery Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Stenosis (the Bologna Registry). 236
The role of the vascular surgeon in transcatheter aortic valve implantation 227
Female gender and mortality in ST-segment-elevation myocardial infarction treated with primary PCI 223
Monocyte-derived tissue factor contributes to stent thrombosis in an in vitro system. 217
Detection of Tissue Factor Antigen and Coagulation Activity in Coronary Artery Thrombi Isolated from Patients with ST-Segment Elevation Acute Myocardial Infarction 212
A randomised comparison between clopidogrel 150 mg daily maintenance dose versus 75 mg in patients with ST-segment elevation acute myocardial infarction undergoing primary percutaneous coronary intervention 204
Baseline white blood cell count is an independent predictor of long-term cardiovascular mortality in patients with non-ST-segment elevation acute coronary syndrome, but it does not improve the risk classification of the GRACE score. 197
Clinical comparison of "normal-hours" vs "off-hours" percutaneous coronary interventions for ST-elevation myocardial infarction. 196
Clinical relevance of homocysteine levels in patients receiving coronary stenting for unstable angina. 191
Long-term clinical and angiographic outcome of patients with occlusive in-stent restenosis treated with (32P) beta-brachytherapy. 187
How many patients with severe symptomatic aortic stenosis excluded for cardiac surgery are eligible for transcatheter heart valve implantation? 182
32P brachytherapy in the treatment of complex Cypher in-stent restenosis. 180
Monocyte-derived tissue factor contributes to stent thrombosis in an in vitro system 177
Diagnostic performance of standard electrocardiogram for prediction of infarct related artery and site of coronary occlusion in unselected STEMI patients undergoing primary percutaneous coronary intervention 176
Long-term effectiveness of early administration of glycoprotein IIb/IIIa agents to real-world patients undergoing primary percutaneous interventions: results of a registry study in an ST-elevation myocardial infarction network. 175
Optimisation of therapeutic strategies for ST-segment elevation acute myocardial infarction: the impact of a territorial network on reperfusion therapy and mortality 174
Prognostic Significance of Baseline White Blood Cell Count in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome. 172
Emerging indications, in-hospital and long-term outcome of balloon aortic valvuloplasty in the transcatheter aortic valve implantation era. 169
Incidence, treatment and outcome of acute coronary syndromes: A community-based study in the era of myocardial infarction networks. 162
Clinical imaging of the vulnerable plaque in the coronary arteries: new intracoronary diagnostic methods. 161
Preprocedural Levels of C-Reactive Protein and Leukocyte Counts Predict 9-Month Mortality After Coronary Angioplasty for the Treatment of Unprotected Left Main Coronary Artery Stenosis. 159
A comparison between coronary artery bypass grafting surgery and drug eluting stent for the treatment of unprotected left main coronary artery disease in elderly patients (aged ³ 75 years) 159
Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients 158
Risk of stroke with coronary artery bypass graft surgery compared with percutaneous coronary intervention. 156
In vitro thrombogenicity of drug-eluting and bare metal stents 156
Elevati livelli pre-procedurali della proteina C-reattiva predicono la mortalita a 9 mesi dall'angioplastica del tronco comune non protetto. 155
Short- and long-term prognostic significance of ST-segment elevation in lead aVR in patients with non-ST-segment elevation acute coronary syndrome. 155
Randomized comparative trial of a thin-strut bare metal cobalt-chromium stent versus a sirolimus-eluting stent for coronary revascularization 155
The role of percutaneous aortic bloon valvuloplasty for severe degenerative aortic valve stenosis in the modern era of interventional cardiology 154
Predictors of complicated athero-thrombotic lesions in non-ST segment acute coronary syndrome. 154
A comparison between coronary artery bypass grafting surgery and drug eluting stent for the treatment of unprotected left main coronary artery disease in elderly patients (aged > or =75 years). 153
Is balloon aortic valvuloplasty safe in patients with significant aortic valve regurgitation? 152
Impact of a territorial ST-segment elevation myocardial infarction network on prognosis of patients with out-of-hospital cardiac arrest. 151
Pre-hospital ECG in patients undergoing primary percutaneous interventions within an integrated system of care: reperfusion times and long-term survival benefits. 149
Prognostic significance of mean platelet volume on admission in an unselected cohort of patients with non ST-segment elevation acute coronary syndrome. 147
Detection of tissue factor antigen and coagulation activity in coronary artery thrombi isolated from patients with ST-segment elevation acute myocardial infarction 145
Risk of stroke in patients with stable coronary artery disease undergoing percutaneous coronary intervention versus optimal medical therapy: Systematic review and meta-analysis of randomized controlled trials 145
La brachiterapia endocoronarica nei pazienti diabetici con ristenosi intrastent. 144
Stent thrombosis with everolimus-eluting stents: meta-analysis of comparative randomized controlled trials. 143
Residual aortic regurgitation is a major determinant of late mortality after transcatheter aortic valve implantation 143
Lower long-term mortality within a regional system of care for ST-elevation myocardial infarction. 141
Usefulness of prehospital triage in patients with cardiogenic shock complicating ST-elevation myocardial infarction treated with primary percutaneous coronary intervention 141
Appraising the impact of left ventricular ejection fraction on outcomes of percutaneous drug-eluting stenting for unprotected left main disease: insights from a multicenter registry of 975 patients. 141
Riduzione del tempo di ritardo terapeutico e della mortalità ospedaliera nei pz con STEMI grazie ad un programma di accesso rapido alla PTCA primaria 140
Early vs. late IIb/IIIa agents administration in primary percutaneous interventions for ST-elevation myocardial infarction: results of a single centre registry 140
Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated with percutaneos coronary intervention 140
Bleeding-Related Deaths in Relation to the Duration of Dual-Antiplatelet Therapy After Coronary Stenting 139
Clinical impact of direct referral to primary percutaneous coronary intervention following pre-hospital diagnosis of ST-elevation myocardial infarction. 139
Long-term effectiveness of early administration of IIb/IIIa agents to high-risk patients undergoing primary percutaneous interventions 137
Short- versus long-term dual antiplatelet therapy after drug-eluting stent implantation: An individual patient data pairwise and network meta-analysis 137
Defining high-risk patients with ST-segment elevation acute myocardial infarction undergoing primary percutaneous coronary intervention: A comparison among different scoring systems and clinical definitions 135
Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated by percutaneous coronary intervention 133
Risk of stroke in patients with high on-clopidogrel platelet reactivity to adenosine diphosphate after percutaneous coronary intervention 132
Pattern of arterial inflammation and inflammatory markers in people living with HIV compared with uninfected people 132
Impact of gene polymorphisms, platelet reactivity, and the SYNTAX score on 1-year clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: The GEPRESS study 130
Impact of SGLT2-inhibitors on acute kidney injury in diabetic patients with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI) 127
Percutaneous revascularization of left main: Role of imaging, techniques and adjunct pharmacology 127
Simultaneous versus staged approach in transcatheter aortic valve implantation for severe stenosis and endovascular aortic repair for thoracic and abdominal aortic aneurysm 126
SHORT AND LONG-TERM PROGNOSTIC SIGNIFICANCE OF ST-SEGMENT ELEVATION IN LEAD AVR IN PATIENTS WITH NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME 125
Impact of Elective, Uncomplicated Target Lesion Revascularization on Cardiac Mortality After Elective Percutaneous Coronary Intervention of Unprotected Left Main Coronary Artery Disease 124
Predictors of beta-brachytherapy failure in patients with high-risk in-stent restenosis 122
One-year outcome of patients eligible to transcatheter aortic valve implantation according to actual treatment 122
Impact of leukocyte count on mortality and bleeding in patients with myocardial infarction undergoing primary percutaneous coronary interventions: analysis from the Harmonizing Outcome with Revascularization and Stent in Acute Myocardial Infarction trial 121
Risk of stroke with percutaneous coronary intervention compared with on-pump and off-pump coronary artery bypass graft surgery: Evidence from a comprehensive network meta-analysis. 121
Risk of stroke in patients with high on clopidrogel platelet reactivity to ADP after percutaneous coronary intervention: systematic review and meta-analysis 120
Coronary Protection to Prevent Coronary Obstruction During Transcatheter Aortic Valve Replacement: A Multicenter International Registry 120
Influence of C-reactive protein on the effectiveness of IIb/IIIa agents in patients with ST-elevation myocardial infarction treated by percutaneous coronary intervention 118
Prognostic importance of ventricular arrhythmia in patients treated with percutaneous coronary intervention. 117
Preoperative C-reactive protein levels predict 9-month mortality after coronary artery bypass grafting surgery for the treatment of left main coronary artery stenosis. 115
Description of an In-vitro of Stent Perfusion to Study Stent Thrombosis at Different Shear Rates 115
Importance and limits of pre-hospital electrocardiogram in patients with ST elevation myocardial infarction undergoing percutaneous coronary angioplasty 115
Predicting and improving outcomes of transcatheter aortic valve replacement in older adults and the elderly 114
Impact of coronary bypass or stenting on mortality and myocardial infarction in stable coronary artery disease 112
Ruolo del fattore tissutale circolante nel determinare la trombosi di stent in un sistema di perfusione in vitro. 111
Correlation between aortic root dimension and coronary ectasia 111
SGLT2-inhibitors in diabetic patients with severe aortic stenosis and cardiac damage undergoing transcatheter aortic valve implantation (TAVI) 110
Biolimus-a9 eluting stent implantion for unprotected left main coronary artery stenosis: 9-month strut coverage as assessed by optical coherence tomography 108
Risk-benefit profile of longer-than-1-year dual-antiplatelet therapy duration after drug-eluting stent implantation in relation to clinical presentation a pairwise meta-analysis of 6 trials and 21 457 patients 108
Sino-tubular junction to sinuses of Valsalva ratio: An echocardiographic parameter to predict coronary artery ectasia in patients with aortic enlargement 105
Reply: Can We State That Placing a Stent Is Sufficient? 101
Predictive value of C-reactive protein on 30-day and 1-year mortality in acute coronary syndromes: an analysis from the ACUITY trial. 99
Risk-Benefit of 1-Year DAPT After DES Implantation in Patients Stratified by Bleeding and Ischemic Risk 99
Early invasive strategy (< 24 hours) in patients with acute coronary syndromes: Weighing the evidence 95
Mortality Following Nonemergent, Uncomplicated Target Lesion Revascularization After Percutaneous Coronary Intervention: An Individual Patient Data Pooled Analysis of 21 Randomized Trials and 32,524 Patients 94
Risk of Stroke of Percutaneous Coronary Intervention in Patients with Stable Coronary Artery Disease: a Systematic Review and Meta-analysis of Contemporary Randomized Clinical Trials 93
Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage StrategY) trial 92
Long-term outcome of prosthesis-patient mismatch after transcatheter aortic valve replacement 92
Coronary ectasia in different scenarios, primarily in myocardial infarction with nonobstructive coronary artery disease 91
Routine minimalist transcatheter aortic valve implantation with local anesthesia only 90
Recapture of the Sapien-3 Delivery System After Transversal Balloon Rupture Using a Whole Percutaneous Femoral Approach 88
Vascular Access in Patients With Peripheral Arterial Disease Undergoing TAVR: The Hostile Registry 87
Surgical risk scores applied to transcatheter aortic valve implantation: Friends or foes? short-term and long-term outcomes from a single-center registry 82
Transcatheter Aortic Valve Replacement for Pure Aortic Regurgitation in a Large and Noncalcified Annulus 82
Efficacia a lungo termine della brachiterapia endocoronarica beta (32P) nel trattamento delle ristenosi intrastent ad elevato rischio. Risultati prospettici di un registro monocentrico 79
Development and validation of the D-PACE scoring system to predict delayed high-grade conduction disturbances after transcatheter aortic valve implantation 75
Reduced Mortality With Antiplatelet Therapy Deescalation After Percutaneous Coronary Intervention in Acute Coronary Syndromes: A Meta-Analysis 75
Long-term echocardiographic findings after TAVR: 5-year follow-up in 400 consecutive patients 75
Emergency balloon aortic valvuloplasty in patients with critical aortic stenosis presenting with cardiogenic shock. 72
Coronary Stent Infection and Subsequent Abscessualization Causing Dislocation in Extravascular Position 67
Totale 13.690
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.494
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.494
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021686 0 0 0 0 0 49 14 66 101 48 62 346
2021/20221.807 194 75 122 164 137 93 35 126 54 130 380 297
2022/20232.185 196 266 128 254 173 179 55 123 394 71 208 138
2023/2024622 46 84 31 78 53 206 19 28 14 34 13 16
2024/20252.497 124 375 196 189 426 162 98 68 30 207 85 537
2025/20262.901 697 598 462 454 634 56 0 0 0 0 0 0
Totale 14.091